INKT
MiNK Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website minktherapeutics.com
- Employees(FY) 37
- ISIN US6036931029
Performance
+12.31%
1W
+11.91%
1M
+9.9%
3M
+2.29%
6M
-5.61%
YTD
-43.89%
1Y
Profile
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. It's product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases and solid tumours, which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc.
Technical Analysis of INKT 2024-05-10
Overview:
In analyzing the technical indicators for the stock of INKT over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been consistently ...
Recent News & Updates
- 2024-05-14 15:04
- 2024-05-13 23:52
INKT Stock Earnings: MiNK Therapeutics Beats EPS for Q1 2024(Investorplace)
- 2024-05-13 19:30
MiNK Reports First Quarter 2024 Results(Globenewswire)
- 2024-05-12 19:30
- 2024-04-29 19:30
- 2024-04-08 00:00
- 2024-03-25 00:00
- 2024-03-22 01:25
- 2024-03-21 11:06
Q4 2023 Mink Therapeutics Inc Earnings Call(Yahoo Finance)
- 2024-03-20 23:53
- 2024-03-20 19:00
MiNK Reports Fourth Quarter and Year-End 2023 Results(Globenewswire)
- 2024-03-06 18:30
- 2024-03-05 19:30
- 2024-02-13 19:00
- 2024-02-05 19:00
- 2024-01-29 19:00
- 2023-12-19 18:30
- 2023-11-08 19:05
- 2023-11-08 18:00
MiNK Therapeutics Reports Third Quarter 2023 Results(Globenewswire)
- 2023-11-03 00:00
- 2023-10-29 20:00
- 2023-09-26 21:05
- 2023-08-23 20:30
- 2023-08-09 19:30
MiNK Therapeutics Reports Second Quarter 2023 Results(Yahoo Finance)
- 2023-07-27 20:30
- 2023-06-04 19:30
- 2023-05-21 20:30
- 2023-05-17 20:30
MiNK's Novel FAP-CAR-iNKT Presented at ASGCT(Yahoo Finance)
- 2023-05-10 20:00
- 2023-04-26 20:30
Page 1 of 3
previousnext